Stocktoria

ARTIVION, INC. AORT

NYSE · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1993-02-12 · LEI

ARTIVION, INC. financials (annual)

Revenue
$180.4M $189.7M $262.8M $276.2M $253.2M $298.8M $313.8M $354.0M $388.5M $441.3M 2016201720182019202020212022202320242025
Net income
$10.8M $3.7M -$2.8M $1.7M -$16.7M -$14.8M -$19.2M -$30.7M -$13.4M $9.8M 2016201720182019202020212022202320242025
Free cash flow
$13.5M $4.2M $4.1M $7.8M $5.0M -$15.7M -$15.9M $9.1M $11.0M $839000 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$441.3M$388.5M$354.0M$313.8M$298.8M$253.2M$276.2M$262.8M$189.7M$180.4M
Gross profit$284.2M$248.8M$229.2M$202.5M$197.5M$167.8M$183.0M$173.0M$128.6M$118.9M
R&D expense$31.0M$28.5M$28.7M$38.9M$35.5M$24.2M$23.0M$23.1M$19.5M$13.4M
SG&A expense$226.5M$181.5M$209.0M$157.4M$169.8M$141.1M$143.0M$140.6M$101.2M$91.5M
Operating income$33.7M$38.9M$5.7M$6.2M$8.1M$2.4M$17.0M$9.3M$8.0M$21.8M
Interest expense$25.3M$18.2M$16.9M$16.7M$14.9M$15.8M$4.9M$3.0M
Income tax$5.0M$5.8M$9.1M$4.2M$7,000-$492,000-$76,000-$3.6M-$143,000$7.6M
Net income$9.8M-$13.4M-$30.7M-$19.2M-$14.8M-$16.7M$1.7M-$2.8M$3.7M$10.8M
EPS (diluted)$0.21$-0.32$-0.75$-0.48$-0.38$-0.44$0.05$-0.08$0.11$0.32
Operating cash flow$39.9M$22.2M$18.8M-$5.2M-$2.6M$12.4M$15.8M$9.9M$10.8M$19.7M
Free cash flow$839,000$11.0M$9.1M-$15.9M-$15.7M$5.0M$7.8M$4.1M$4.2M$13.5M
Cash & equivalents$64.9M$53.5M$58.9M$39.4M$55.0M$61.4M$33.8M$41.5M$40.0M$56.6M
Inventory$92.4M$79.8M$82.0M$74.5M$77.0M$73.0M$53.1M$45.5M$46.7M$26.3M
Total assets$884.8M$789.1M$792.4M$762.8M$793.1M$789.4M$605.7M$571.1M$589.7M$316.1M
Total liabilities$436.6M$512.9M$510.6M$478.5M$492.3M$460.7M$320.0M$296.0M$312.6M$107.2M
Shareholders' equity$448.2M$276.2M$281.8M$284.3M$300.7M$328.7M$285.7M$275.1M$277.1M$209.0M

Growth · year-over-year · Revenue CAGR 10.5%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth+13.6%+9.8%+12.8%+5.0%+18.0%-8.3%+5.1%+38.6%+5.2%+23.6%
Net income growth-1069.9%-176.7%-65.6%+169.1%
EPS growth-980.0%-172.7%-65.6%+128.6%
Free cash flow growth-92.4%+21.8%-411.0%-35.0%+89.4%-1.8%-69.2%+70.0%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.